Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Dry Eye Syndrome Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global dry eye syndrome market reached a value of US$ 3.9 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 6.6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Dry eye syndrome, medically known as keratoconjunctivitis sicca (KCS), is a term that defines the lack of lubrication or moisture on the surface of the infected person’s eyes. It is a commonly occurring disease which can affect almost anyone. Various symptoms of dry eye include aching and burning sensations, sore eyes, red eyes, fatigued eyes, itchy eyes, photophobia, etc. Apart from this, watery eyes can also be a symptom as the dry surface of the eyes over-stimulate the production of watery component of tears in order to reduce the dryness. There are several factors that can cause dry eye syndrome such as excessive computer uses, allergies, aging, menopause, smoking, LASIK eye surgery, hormone replacement therapy, etc.

Various diseases, such as diabetes, thyroid disorders, Sjogren’s syndrome, lupus, scleroderma, rheumatoid arthritis, etc., are also contributing to the prevalence of dry eyes among people. As per statistics, around 425-430 Million individuals across the globe get affected by diabetes. It causes constant changes in the composition of patient’s blood which adversely affects the tear glands resulting in a rising prevalence of dry eye. Another key factor which is contributing to the growth of the market is the rising geriatric population. As per estimates, around 9% of the global population is above 65 years of age, and by 2050 this segment is expected to account for around 17% of the global population. With the prevalence of dry eyes being high among the elderly, we expect the market for dry eye syndrome to exhibit a strong growth. Other factors augmenting the growth of this market include increasing awareness levels, rising diagnostic rates, better treatment options, etc.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global dry eye syndrome market report, along with forecasts for growth at the global and regional level from 2021-2026. Our report has categorized the market based on disease type, drug type, product and distribution channel.

Breakup by Disease Type:

  • Evaporative
  • Aqueous


Based on the disease type, evaporative dry eye syndrome currently accounts for the highest market share.

Breakup by Drug Type:

  • Anti-inflammatory Drugs
  • Lubricant Eye Drops
  • Autologous Serum Eye Drops


Based on the drug type, anti-inflammatory drugs currently account for the highest market share.

Breakup by Product:

  • Liquid Drops
  • Gel
  • Liquid Wipes
  • Eye Ointment
  • Others


Based on the product type, liquid eye drops currently account for the highest market share.

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies


Based on the distribution channel, hospital pharmacies currently account for the highest market share.

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America
     

On the geographical front, North America currently represents the biggest market for dry eye syndrome.

Competitive Landscape:

The competitive landscape of the market has also been examined with some of the key players being, Akorn Inc., Alimera Science, Allergan plc., Auven Therapeutics, Bausch + Lomb, GlaxoSmithKline plc, Nicox S.A., Novartis AG, Otsuka Holdings Co. Ltd., and Santen Pharmaceutical Co. Ltd.

Report Coverage:

Report Features Details
Base Year of the Analysis 2020
Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Disease Type, Drug Type, Product, Distribution Channel, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Companies Covered Akorn Inc., Alimera Science, Allergan plc., Auven Therapeutics, Bausch + Lomb, GlaxoSmithKline plc, Nicox S.A., Novartis AG, Otsuka Holdings Co. Ltd., and Santen Pharmaceutical Co. Ltd.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License $ 1999
Five User License $ 2499
Corporate License $ 2999
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Dry Eye Syndrome Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Breakup by Disease Type 
    5.5    Market Breakup by Drug Type 
    5.6    Market Breakup by Product 
    5.7    Market Breakup by Distribution Channels 
    5.8    Market Breakup by Region 
    5.9    Market Forecast
6   Market Breakup by Disease Type 
    6.1    Evaporative Dry Eye Syndrome 
        6.1.1    Market Trends
        6.1.2    Market Forecast
    6.2    Aqueous Dry Eye Syndrome
        6.2.1    Market Trends
        6.2.2    Market Forecast
7   Market Breakup by Drug Type
    7.1    Anti-inflammatory Drugs
        7.1.1    Market Trends
        7.1.2    Market Forecast
    7.2    Lubricant Eye Drops
        7.2.1    Market Trends
        7.2.2    Market Forecast
    7.3    Autologous Serum Eye Drops 
        7.3.1    Market Trends
        7.3.2    Market Forecast
8   Market Breakup by Product 
    8.1    Liquid Drops 
        8.1.1    Market Trends
        8.1.2    Market Forecast
    8.2    Gel 
        8.2.1    Market Trends
        8.2.2    Market Forecast
    8.3    Liquid Wipes 
        8.3.1    Market Trends
        8.3.2    Market Forecast
    8.4    Eye Ointment 
        8.4.1    Market Trends
        8.4.2    Market Forecast
    8.5    Others
        8.5.1    Market Trends
        8.5.2    Market Forecast
9   Market Breakup by Distribution Channel
    9.1    Hospital Pharmacies
        9.1.1    Market Trends
        9.1.2    Market Forecast
    9.2    Retail Pharmacies
        9.2.1    Market Trends
        9.2.2    Market Forecast
    9.3    Online Pharmacies 
        9.3.1    Market Trends
        9.3.2    Market Forecast
10 Market Breakup by Region
    10.1    North America
        10.1.1    Market Trends
        10.1.2    Market Forecast
    10.2    Europe
        10.2.1    Market Trends
        10.2.2    Market Forecast
    10.3    Asia Pacific
        10.3.1    Market Trends
        10.3.2    Market Forecast
    10.4    Middle East and Africa
        10.4.1    Market Trends
        10.4.2    Market Forecast
    10.5    Latin America
        10.5.1    Market Trends
        10.5.2    Market Forecast
11 Global Dry Eye Syndrome Industry: SWOT Analysis 
    11.1    Overview 
    11.2    Strengths
    11.3    Weaknesses 
    11.4    Opportunities
    11.5    Threats
12 Global Dry Eye Syndrome Industry: Value Chain Analysis 
13 Global Dry Eye Syndrome Industry: Porters Five Forces Analysis 

    13.1    Overview 
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers 
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14 Global Dry Eye Syndrome Industry: Price Analysis 
    14.1    Price Indicators
    14.2    Price Structure
    14.3    Margin Analysis
15 Manufacturing Process
    15.1    Product Overview
    15.2    Raw Material Requirements
    15.3    Manufacturing Process
    15.4    Key Success and Risk Factors
16 Competitive Landscape
    16.1    Market Structure
    16.2    Key Players
    16.3    Profiles of Key Players
        16.3.1    Akorn, Inc.
        16.3.2    Alimera Science
        16.3.3    Allergan plc.
        16.3.4    Auven Therapeutics
        16.3.5    Bausch + Lomb
        16.3.6    GlaxoSmithKline plc
        16.3.7    Nicox S.A.
        16.3.8    Novartis AG 
        16.3.9    Otsuka Holdings Co., Ltd.
        16.3.10   Santen Pharmaceutical Co., Ltd.

List of Figures

Figure 1: Global: Dry Eye Syndrome Market: Major Drivers and Challenges
Figure 2: Global: Dry Eye Syndrome Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Dry Eye Syndrome Market: Breakup by Disease Type (in %), 2020
Figure 4: Global: Dry Eye Syndrome Market: Breakup by Drug Type (in %), 2020
Figure 5: Global: Dry Eye Syndrome Market: Breakup by Product (in %), 2020
Figure 6: Global: Dry Eye Syndrome Market: Breakup Distribution Channel (in %), 2020
Figure 7: Global: Dry Eye Syndrome Market: Breakup by Region (in %), 2020
Figure 8: Global: Dry Eye Syndrome Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 9: Global: Dry Eye Syndrome (Evaporative) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Dry Eye Syndrome (Evaporative) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Dry Eye Syndrome (Aqueous) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Dry Eye Syndrome (Aqueous) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Dry Eye Syndrome (Anti-inflammatory Drugs) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Dry Eye Syndrome (Anti-inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Dry Eye Syndrome (Lubricant Eye Drops) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Dry Eye Syndrome (Lubricant Eye Drops) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Dry Eye Syndrome (Autologous Serum Eye Drops) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Dry Eye Syndrome (Autologous Serum Eye Drops) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Dry Eye Syndrome (Liquid Drops) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Dry Eye Syndrome (Liquid Drops) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Dry Eye Syndrome (Gel) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Dry Eye Syndrome (Gel) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Dry Eye Syndrome (Liquid Wipes) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Dry Eye Syndrome (Liquid Wipes) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Dry Eye Syndrome (Eye Ointment) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Global: Dry Eye Syndrome (Eye Ointment) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Global: Dry Eye Syndrome (Other Product Types) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Global: Dry Eye Syndrome (Other Product Types) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Global: Dry Eye Syndrome (Hospital Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Global: Dry Eye Syndrome (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: Global: Dry Eye Syndrome (Retail) Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: Global: Dry Eye Syndrome (Retail) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Global: Dry Eye Syndrome (Online Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Global: Dry Eye Syndrome (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: North America: Dry Eye Syndrome Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: North America: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Europe: Dry Eye Syndrome Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Europe: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Asia Pacific: Dry Eye Syndrome Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Asia Pacific: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: Middle East and Africa: Dry Eye Syndrome Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: Middle East and Africa: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: Latin America: Dry Eye Syndrome Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: Latin America: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: Global: Dry Eye Syndrome Industry: SWOT Analysis
Figure 46: Global: Dry Eye Syndrome Industry: Value Chain Analysis
Figure 47: Global: Dry Eye Syndrome Industry: Porter’s Five Forces Analysis
Figure 48: Dry Eye Syndrome Manufacturing: Process Flow

List of Tables

Table 1: Global: Dry Eye Syndrome Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Dry Eye Syndrome Market Forecast: Breakup by Disease Type (in Million US$), 2021-2026
Table 3: Global: Dry Eye Syndrome Market Forecast: Breakup by Drug Type (in Million US$), 2021-2026
Table 4: Global: Dry Eye Syndrome Market Forecast: Breakup by Product (in Million US$), 2021-2026
Table 5: Global: Dry Eye Syndrome Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
Table 6: Global: Dry Eye Syndrome Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 7: Dry Eye Syndrome: Raw Material Requirements
Table 8: Global: Dry Eye Syndrome Market Structure
Table 9: Global: Dry Eye Syndrome Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Question Answered in this Report

 

The global dry eye syndrome market was valued at US$ 3.9 Billion in 2020.

 

We expect the global dry eye syndrome market to exhibit a CAGR of 6.6% during 2021-2026.

 

Increasing prevalence of dry eye syndrome as a common symptom for numerous medical ailments, such as Sjogren’s syndrome, lupus, scleroderma, rheumatoid arthritis, etc., represents one of the key factors driving the global dry eye syndrome market.

 

Sudden outbreak of the COVID-19 pandemic had led to a severe decline in hospital or clinic visits for mitigating the risk of coronavirus infection, thereby negatively impacting the demand for dry eye syndrome diagnosis and treatment procedures. 

 

Based on the disease type, the global dry eye syndrome market has been divided into evaporative dry eye syndrome and aqueous dry eye syndrome, where evaporative dry eye syndrome currently holds the majority of the total market share.

 

Based on the drug type, the global dry eye syndrome market can be segregated into lubricant eye drops, anti-inflammatory drugs, and autologous serum eye drops. Among these, anti-inflammatory drugs exhibit the clear dominance in the market. 

 

Based on the product, the global dry eye syndrome market has been bifurcated into liquid drops, gel, liquid wipes, eye ointment, and others. Currently, liquid eye drops represent the majority of the total market share.

 

Based on the distribution channel, the global dry eye syndrome market can be categorized into retail pharmacies, hospital pharmacies, and online pharmacies. Among these, hospital pharmacies currently account for the largest market share.

On a regional level, the market has been classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America, where North America currently dominates the global market. 

 

 

Some of the major players in the global dry eye syndrome market include Akorn Inc., Alimera Science, Allergan plc., Auven Therapeutics, Bausch + Lomb, GlaxoSmithKline plc, Nicox S.A., Novartis AG, Otsuka Holdings Co. Ltd., and Santen Pharmaceutical Co. Ltd.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 1999

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links